Sacituzumab Govitecan (IMMU-132) in treatment-resistant uterine serous carcinoma: A case report

Background: Uterine serous carcinoma (USC) is a biologically aggressive variant of uterine cancer. Effective treatment options for recurrent, chemotherapy-resistant USC are extremely limited. Case: We describe a 74-year-old woman with recurrent and widespread treatment-resistant disease, who experie...

Full description

Saved in:
Bibliographic Details
Main Authors: Chanhee Han (Author), Stefania Bellone (Author), Peter E. Schwartz (Author), Serengulam V. Govindan (Author), Robert M. Sharkey (Author), David M. Goldenberg (Author), Alessandro D. Santin (Author)
Format: Book
Published: Elsevier, 2018-08-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available